Study to Gather Information on the Acceptability of a New Flavor System With Increasing Levels of 2, 4, 6 g or Higher of Mannitol for PEG 3350 in Subjects Having Infrequent Bowel Movements.

Phase 4 Completed 50 enrolled Bayer

Non-randomizedParallel-groupOpen-labelTreatment

Summary

Study to gather information on the acceptability of a new flavor system with increasing levels of 2, 4, 6 g or higher of the sugar alcohol Mannitol for Polyethylene glycol (PEG) 3350 a drug stimulating bowel movement to pass stool in subjects having infrequent bowel movements. The taste of the various preparations will be measured by use of a rating scale.

Timeline

Start: 2013-02-13
Primary completion: 2013-03-19
Completion: 2013-03-19

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Mannitol	Diagnostic / imaging agent	2 g	Oral
Subject	Mannitol	Diagnostic / imaging agent	4 g	Oral
Subject	Mannitol	Diagnostic / imaging agent	6 g	Oral
Subject	Mannitol	Diagnostic / imaging agent	8 g	Oral
Subject	Mannitol	Diagnostic / imaging agent	10 g	Oral
Background	polyethylene glycol	Other / unclassified	17 g	Oral

Study to Gather Information on the Acceptability of a New Flavor System With Increasing Levels of 2, 4, 6 g or Higher of Mannitol for PEG 3350 in Subjects Having Infrequent Bowel Movements.

Summary

Timeline

Drugs

Indications